Cyclo Therapeutics, Inc.
CYTH · NASDAQ
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Market Cap | $25,964 | $11,984 | $23,760 | $6,957 |
| - Cash | $9,247 | $1,543 | $16,613 | $12,846 |
| + Debt | $1,033 | $0 | $171 | $194 |
| Enterprise Value | $17,751 | $10,440 | $7,319 | -$5,695 |
| Revenue | $1,076 | $1,376 | $1,586 | $903 |
| % Growth | -21.8% | -13.2% | 75.5% | – |
| Gross Profit | $978 | $1,237 | $1,430 | $837 |
| % Margin | 90.9% | 89.9% | 90.2% | 92.7% |
| EBITDA | -$20,031 | -$15,602 | -$14,270 | -$8,949 |
| % Margin | -1,860.9% | -1,134.1% | -899.9% | -990.6% |
| Net Income | -$20,057 | -$15,280 | -$14,305 | -$8,923 |
| % Margin | -1,863.4% | -1,110.7% | -902.1% | -987.7% |
| EPS Diluted | -1.23 | -1.81 | -2.25 | -5.58 |
| % Growth | 32% | 19.6% | 59.7% | – |
| Operating Cash Flow | -$16,185 | -$15,114 | -$15,005 | -$8,540 |
| Capital Expenditures | -$2 | -$15 | -$23 | -$53 |
| Free Cash Flow | -$16,187 | -$15,129 | -$15,028 | -$8,593 |